UCB Korea's Xyzal to get approval of additional indications.
The company said that of all anti-histaminics only Xyzal took the indication for the treatment of allergic rhinitis from the health authority.
The KFDA said th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
